Location History:
- Eke-Nazareth, BE (2011)
- Nazareth, BE (2005 - 2015)
Company Filing History:
Years Active: 2005-2015
Title: August Verbruggen: Innovator in Spondyloarthropathy Research
Introduction
August Verbruggen is a notable inventor based in Nazareth, Belgium. He has made significant contributions to the field of medical research, particularly in the diagnosis and monitoring of spondyloarthropathy. With a total of 4 patents, his work has the potential to impact patient care and treatment options.
Latest Patents
One of his latest patents involves the use of GDF15 as a differential marker for spondyloarthropathy. This invention discloses in vitro methods for the differential diagnosis of spondyloarthropathy by determining the levels of GDF15 in biological samples. Another significant patent is a scoring system designed to monitor natural or drug-modified disease progression in erosive osteoarthritis of the interphalangeal finger joints. This scoring system aims to identify and evaluate drugs with anticatabolic and/or repair-promoting potential.
Career Highlights
Throughout his career, August Verbruggen has worked with esteemed institutions such as Universiteit Gent and Ghent University. His research has focused on advancing the understanding of osteoarthritis and related conditions, contributing valuable insights to the medical community.
Collaborations
He has collaborated with notable professionals in his field, including Dirk Elewaut and Eric Maximilien Veys. These partnerships have further enriched his research and innovation efforts.
Conclusion
August Verbruggen's work exemplifies the intersection of innovation and medical research, particularly in the realm of spondyloarthropathy. His contributions through patents and collaborations continue to pave the way for advancements in diagnosis and treatment.